Steven J. Kuerbitz

3.1k total citations · 1 hit paper
19 papers, 2.6k citations indexed

About

Steven J. Kuerbitz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Steven J. Kuerbitz has authored 19 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Steven J. Kuerbitz's work include Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (6 papers) and Renal and related cancers (5 papers). Steven J. Kuerbitz is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (6 papers) and Renal and related cancers (5 papers). Steven J. Kuerbitz collaborates with scholars based in United States, Singapore and Pakistan. Steven J. Kuerbitz's co-authors include Michael B. Kastan, William Walsh, Beverly Plunkett, Stephen B. Baylin, Wafik S. El‐Deiry, Webster K. Cavenee, Barry D. Nelkin, Jean‐Pierre J. Issa, S B Baylin and Manel Esteller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Steven J. Kuerbitz

19 papers receiving 2.6k citations

Hit Papers

Wild-type p53 is a cell cycle checkpoint determinant foll... 1992 2026 2003 2014 1992 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    1992 1.6k citations Steven J. Kuerbitz, Beverly Plunkett et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven J. Kuerbitz United States 10 1.8k 1.6k 473 438 247 19 2.6k
J. Wade Harper United States 2 1.3k 0.7× 1.4k 0.9× 403 0.9× 328 0.7× 139 0.6× 3 2.0k
Charanjit Sandhu Canada 11 1.7k 0.9× 1.7k 1.1× 337 0.7× 191 0.4× 153 0.6× 11 2.4k
Birgitte Smith‐Sørensen Norway 17 1.4k 0.8× 1.4k 0.9× 674 1.4× 236 0.5× 251 1.0× 25 2.4k
Sun W. Tam United States 14 2.2k 1.2× 2.1k 1.3× 394 0.8× 202 0.5× 278 1.1× 17 3.2k
Rebecca Haffner Israel 12 1.8k 1.0× 1.4k 0.9× 336 0.7× 383 0.9× 86 0.3× 15 2.3k
Inga Reynisdóttir Iceland 15 2.0k 1.1× 1.5k 1.0× 342 0.7× 187 0.4× 200 0.8× 25 2.8k
Ying C. Henderson United States 25 1.3k 0.7× 1.0k 0.6× 509 1.1× 163 0.4× 131 0.5× 39 2.4k
Peter vanTuinen United States 14 1.1k 0.6× 1.3k 0.8× 584 1.2× 242 0.6× 602 2.4× 25 2.5k
Anne M. Theodoras United States 8 2.5k 1.4× 2.1k 1.3× 399 0.8× 186 0.4× 186 0.8× 8 3.2k
Charles Catzavelos Canada 14 2.1k 1.2× 1.6k 1.0× 435 0.9× 117 0.3× 234 0.9× 18 3.0k

Countries citing papers authored by Steven J. Kuerbitz

Since Specialization
Citations

This map shows the geographic impact of Steven J. Kuerbitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Kuerbitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Kuerbitz more than expected).

Fields of papers citing papers by Steven J. Kuerbitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Kuerbitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Kuerbitz. The network helps show where Steven J. Kuerbitz may publish in the future.

Co-authorship network of co-authors of Steven J. Kuerbitz

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Kuerbitz. A scholar is included among the top collaborators of Steven J. Kuerbitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Kuerbitz. Steven J. Kuerbitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ball, Hope C., et al.. (2025). Epigenetic Inactivation of RIPK3-Dependent Necroptosis Augments Cisplatin Chemoresistance in Human Osteosarcoma. International Journal of Molecular Sciences. 26(8). 3863–3863. 1 indexed citations
2.
Steele, Mark A., et al.. (2020). Aberrant epigenetic silencing of neuronatin is a frequent event in human osteosarcoma. Oncotarget. 11(20). 1876–1893. 9 indexed citations
3.
Kuerbitz, Steven J.. (2020). Osteosarcoma: A review with emphasis on pathogenesis and chemoresistance. Medical Research Archives. 8(7). 3 indexed citations
4.
Kuerbitz, Steven J., et al.. (2019). WT1 regulates cyclin�A1 expression in K562�cells. Oncology Reports. 42(5). 2016–2028. 2 indexed citations
5.
Snyder, Douglas K., et al.. (2013). Abstract 773: WT1 regulation of Cyclin A1 in leukemia.. Cancer Research. 73(8_Supplement). 773–773. 1 indexed citations
6.
Agamanolis, Dimitri P., Christos D. Katsetos, Henry M. Bartkowski, et al.. (2012). An Unusual Form of Superficially Disseminated Glioma in Children. Journal of Child Neurology. 27(6). 727–733. 23 indexed citations
7.
Eisermann, Kurtis, et al.. (2011). The Importance of WT1 in Leukemia. Blood. 118(21). 4645–4645. 2 indexed citations
8.
Eisermann, Kurtis, et al.. (2010). Identifying a role for WT1 in pediatric leukemia.. Journal of Clinical Oncology. 28(15_suppl). e20005–e20005. 1 indexed citations
9.
Hinshaw, Molly, et al.. (2004). Three Children with CD30+ Cutaneous Anaplastic Large Cell Lymphomas Bearing the t(2;5)(p23;q35) Translocation. Pediatric Dermatology. 21(3). 212–217. 15 indexed citations
10.
Kuerbitz, Steven J.. (2002). Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia. Carcinogenesis. 23(4). 559–564. 45 indexed citations
11.
Kuerbitz, Steven J., et al.. (1999). Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.. PubMed. 10(1). 27–33. 6 indexed citations
12.
Corn, Paul G., Steven J. Kuerbitz, Max M. van Noesel, et al.. (1999). Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.. PubMed. 59(14). 3352–6. 245 indexed citations
13.
Kuerbitz, Steven J. & S B Baylin. (1996). Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase.. PubMed. 7(6). 847–53. 9 indexed citations
14.
El‐Deiry, Wafik S., Barry D. Nelkin, Jean‐Pierre J. Issa, et al.. (1995). p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Medicine. 1(6). 570–577. 366 indexed citations
15.
Kastan, Michael B. & Steven J. Kuerbitz. (1993). Control of G1 arrest after DNA damage.. Environmental Health Perspectives. 101(suppl 5). 55–58. 53 indexed citations
16.
Kastan, Michael B. & Steven J. Kuerbitz. (1993). Control of G 1 Arrest after DNA Damage. Environmental Health Perspectives. 101. 55–55. 24 indexed citations
17.
Kuerbitz, Steven J., Curt I. Civin, J. Krischer, et al.. (1992). Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 10(9). 1419–1429. 51 indexed citations
18.
Kuerbitz, Steven J., Beverly Plunkett, William Walsh, & Michael B. Kastan. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation.. Proceedings of the National Academy of Sciences. 89(16). 7491–7495. 1597 indexed citations breakdown →
19.
Kastan, Michael B., Arthur I. Radin, Steven J. Kuerbitz, et al.. (1991). Levels of p53 protein increase with maturation in human hematopoietic cells.. PubMed. 51(16). 4279–86. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Wade Harper Breakdown of academic impact, for papers by Charanjit Sandhu Breakdown of academic impact, for papers by Birgitte Smith‐Sørensen Breakdown of academic impact, for papers by Sun W. Tam Breakdown of academic impact, for papers by Rebecca Haffner Breakdown of academic impact, for papers by Inga Reynisdóttir Breakdown of academic impact, for papers by Ying C. Henderson Breakdown of academic impact, for papers by Peter vanTuinen Breakdown of academic impact, for papers by Anne M. Theodoras Breakdown of academic impact, for papers by Charles Catzavelos
Rankless by CCL
2026